961 related articles for article (PubMed ID: 10232612)
21. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
22. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
24. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells.
Grossman EM; Longo WE; Panesar N; Mazuski JE; Kaminski DL
Carcinogenesis; 2000 Jul; 21(7):1403-9. PubMed ID: 10874020
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
26. The effects of cyclooxygenase-2 inhibitors on urological cancer cells.
Yoshimura R; Matsuyama M; Kawahito Y; Takemoto Y; Tsuchida K; Kuratsukuri K; Segawa Y; Shinnka T; Sano H; Nakatani T
Int J Mol Med; 2004 Jun; 13(6):789-93. PubMed ID: 15138613
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
Vadlamudi R; Mandal M; Adam L; Steinbach G; Mendelsohn J; Kumar R
Oncogene; 1999 Jan; 18(2):305-14. PubMed ID: 9927187
[TBL] [Abstract][Full Text] [Related]
29. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
30. 5-LOX inhibitor modulates the inflammatory responses provoked by Helicobacter pylori infection.
Park S; Han SU; Lee KM; Park KH; Cho SW; Hahm KB
Helicobacter; 2007 Feb; 12(1):49-58. PubMed ID: 17241301
[TBL] [Abstract][Full Text] [Related]
31. Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP.
Johnson KP; Rowe GC; Jackson BA; D'Agustino JL; Campbell PE; Guillory BO; Williams MV; Matthews QL; McKay J; Charles GM; Verret CR; Deleon M; Johnson DE; Cooke DB
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1039-45. PubMed ID: 11785654
[TBL] [Abstract][Full Text] [Related]
32. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
34. Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism.
Hammamieh R; Sumaida D; Zhang X; Das R; Jett M
BMC Cancer; 2007 Jul; 7():138. PubMed ID: 17651499
[TBL] [Abstract][Full Text] [Related]
35. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
36. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
37. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
Avis IM; Jett M; Boyle T; Vos MD; Moody T; Treston AM; MartÃnez A; Mulshine JL
J Clin Invest; 1996 Feb; 97(3):806-13. PubMed ID: 8609238
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
Ermert L; Dierkes C; Ermert M
Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
[TBL] [Abstract][Full Text] [Related]
40. Expression of 15-lipoxygenase-1 in human colorectal cancer.
Ikawa H; Kamitani H; Calvo BF; Foley JF; Eling TE
Cancer Res; 1999 Jan; 59(2):360-6. PubMed ID: 9927047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
